New product approved in US for haemophilia A
The FDA has recently approved the Wyeth product Xyntha™ for the control and prevention of bleeding episodes and for surgical prophylaxis in patients diagnosed with haemophilia A.
The FDA has recently approved the Wyeth product Xyntha™ for the control and prevention of bleeding episodes and for surgical prophylaxis in patients diagnosed with haemophilia A.
